Trials / Completed
CompletedNCT00331578
Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2,077 (actual)
- Sponsor
- JW Medical Systems Ltd · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The trial aims to evaluate 12-month long-term efficiency of Excel stent in the treatment of coronary heart disease and inhibition of restenosis after coronary artery stenting as well as a 12 months' long-term safety after the cessation of clopidogrel as an anti-platelet drugs used for 6 months after the implantation of degradable drug coating stent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Excel drug-eluting coronary artery stent |
Timeline
- Start date
- 2006-06-01
- Completion
- 2006-12-01
- First posted
- 2006-05-31
- Last updated
- 2009-01-21
Source: ClinicalTrials.gov record NCT00331578. Inclusion in this directory is not an endorsement.